GALLIVAC IB88

Country: Ireland

Language: English

Source: HPRA (Health Products Regulatory Authority)

Active ingredient:

Live attenuated infectious bronchitis coronavirus, (strain CR88121) (793B)

Available from:

Merial Animal Health Limited

ATC code:

QI01AD07

INN (International Name):

Live attenuated infectious bronchitis coronavirus, (strain CR88121) (793B)

Dosage:

4.0-5.3 log 10 50% embryo infective dose/dose

Pharmaceutical form:

Powder for nebuliser suspension

Prescription type:

POM: Prescription Only Medicine as defined in relevant national legislation

Therapeutic group:

Chickens

Therapeutic area:

avian infectious bronchitis virus

Therapeutic indications:

Immunological - Live Vaccine

Authorization status:

Authorised

Authorization date:

2003-06-23

Summary of Product characteristics

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
GALLIVAC IB88.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each dose of reconstituted vaccine contains:
Attenuated Infectious Bronchitis coronavirus, strain CR88121 (793B),
at least 4.0 log
10
EID
50
Excipient q.s. 1 dose
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Powder for nebuliser suspension.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Broiler chickens from 14 days of age.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Reduces clinical
signs and lesions of respiratory disease caused by the coronavirus
variant,
strain CR88 (793B) in
broiler chickens.
Immunity has been demonstrated 17 days after vaccination, and the
duration of immunity is at least 5 weeks.
4.3 CONTRAINDICATIONS
In the absence of trial data, furure layers or breeders and chickens
in lay must not be vaccinated.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Gallivac IB88 vaccination does not replace the vaccination schedule
against classical Infectious Bronchitis.
I
R
I
S
H
M
E
D
I
C
I
N
E
S
B
O
A
R
D
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_1_
_5_
_/_
_0_
_6_
_/_
_2_
_0_
_1_
_2_
_C_
_R_
_N_
_ _
_7_
_0_
_1_
_2_
_7_
_9_
_6_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Only healthy birds should be vaccinated.
The vaccine virus can spread to non-vaccinated birds, but no trend
towards reversion to virulence was demonstrated in
laboratory trials.
Nevertheless,
care should be taken to preve